Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism
Clinical trial NCT01673646 · COMPLETED
Trial details
- NCT number
- NCT01673646
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-16
- Primary completion
- 2017-04-10
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.